IL87608A0 - Recombinant dna-derived bordetella toxin subunit analogs - Google Patents

Recombinant dna-derived bordetella toxin subunit analogs

Info

Publication number
IL87608A0
IL87608A0 IL87608A IL8760888A IL87608A0 IL 87608 A0 IL87608 A0 IL 87608A0 IL 87608 A IL87608 A IL 87608A IL 8760888 A IL8760888 A IL 8760888A IL 87608 A0 IL87608 A0 IL 87608A0
Authority
IL
Israel
Prior art keywords
recombinant dna
derived
subunit analogs
toxin subunit
bordetella
Prior art date
Application number
IL87608A
Other languages
English (en)
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26788722&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL87608(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Amgen Inc filed Critical Amgen Inc
Priority to IL10312188A priority Critical patent/IL103121A/en
Publication of IL87608A0 publication Critical patent/IL87608A0/xx
Priority to IL103121A priority patent/IL103121A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K2039/10—Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
IL87608A 1987-09-04 1988-08-30 Recombinant dna-derived bordetella toxin subunit analogs IL87608A0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IL10312188A IL103121A (en) 1987-09-04 1988-08-30 Analogs of subordinate toxin subunits consisting of DNA and derivatives
IL103121A IL103121A0 (en) 1987-09-04 1992-09-09 Recombinant dna-derived bordetella toxin subunit analogs

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9430787A 1987-09-04 1987-09-04
US23248288A 1988-08-17 1988-08-17

Publications (1)

Publication Number Publication Date
IL87608A0 true IL87608A0 (en) 1989-01-31

Family

ID=26788722

Family Applications (3)

Application Number Title Priority Date Filing Date
IL10312188A IL103121A (en) 1987-09-04 1988-08-30 Analogs of subordinate toxin subunits consisting of DNA and derivatives
IL87608A IL87608A0 (en) 1987-09-04 1988-08-30 Recombinant dna-derived bordetella toxin subunit analogs
IL103121A IL103121A0 (en) 1987-09-04 1992-09-09 Recombinant dna-derived bordetella toxin subunit analogs

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL10312188A IL103121A (en) 1987-09-04 1988-08-30 Analogs of subordinate toxin subunits consisting of DNA and derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL103121A IL103121A0 (en) 1987-09-04 1992-09-09 Recombinant dna-derived bordetella toxin subunit analogs

Country Status (16)

Country Link
US (1) US5773600A (no)
EP (2) EP0306318B2 (no)
JP (1) JP2918895B2 (no)
KR (1) KR0168039B1 (no)
CN (1) CN1033866C (no)
AT (1) ATE125568T1 (no)
CA (1) CA1341560C (no)
DE (1) DE3854213T3 (no)
DK (1) DK175821B1 (no)
ES (1) ES2076160T5 (no)
FI (1) FI101632B1 (no)
GR (1) GR3017497T3 (no)
IE (1) IE69753B1 (no)
IL (3) IL103121A (no)
NO (2) NO301844B1 (no)
WO (1) WO1989001976A1 (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6713072B1 (en) * 1987-11-02 2004-03-30 Chiron S.R.L. Immunologically active polypeptides with altered toxicity useful for the preparation of an antipertussis vaccine
IT1223334B (it) * 1987-11-02 1990-09-19 Sclavo Spa Polipeptidi immunologicamente attivi con una tossicita' alterata utili per la preparazione di un vaccino antipertosse
US5925546A (en) * 1987-11-02 1999-07-20 Chiron S.P.A. Immunologically active polypeptides with altered toxicity useful for the preparation of an antipertussis vaccine
US5332583A (en) * 1987-11-24 1994-07-26 Connaught Laboratories Limited Vaccine containing genetically-detoxified pertussis holotoxin
GB8727489D0 (en) * 1987-11-24 1987-12-23 Connaught Lab Detoxification of pertussis toxin
US5358868A (en) * 1987-11-24 1994-10-25 Connaught Laboratories Limited Genetic detoxification of pertussis toxin
CA2009991A1 (en) * 1989-02-15 1990-08-15 Witold Cieplak Pertussis toxin gene: cloning and expression of protective antigen
US7232671B2 (en) * 1989-02-15 2007-06-19 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Pertussis toxin gene: cloning and expression of protective antigen
EP0396964B1 (en) * 1989-04-28 1995-09-06 SCLAVO S.p.A. Pertussis toxin mutants, bordetella strains capable of producing such mutants and their use in the development of antipertussis vaccines
US5786189A (en) * 1989-11-29 1998-07-28 Smithkline Beecham Biologicals (S.A.) Vaccine
GB9326174D0 (en) * 1993-12-22 1994-02-23 Biocine Sclavo Mucosal adjuvant
US20030072774A1 (en) * 1994-06-10 2003-04-17 Diane M. Gajewczyk Proteinaceous adjuvants
EP0824358B1 (en) * 1995-05-04 2002-12-04 Aventis Pasteur Limited Acellular pertussis vaccines and methods of preparation thereof
EP0912726A4 (en) * 1996-05-10 2001-07-18 Phylomed Corp METHODS FOR OXIDIZING BISULFIDE LINKS WITH OZONE
FR2754543B1 (fr) * 1996-10-11 1998-12-31 Pasteur Institut Souche de bordetella deficiente dans la production de toxine et exprimant une proteine hydride, liposomes comprenant de la fha et leurs utilisations comme vaccins, et utilisation de la fha pour stimuler les reponses immunitaires
US6818222B1 (en) 1997-03-21 2004-11-16 Chiron Corporation Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
GB0313916D0 (en) 2003-06-16 2003-07-23 Glaxosmithkline Biolog Sa Vaccine composition
BRPI0513826A2 (pt) 2004-07-26 2010-06-22 Dow Global Technologies Inc processo para expressão de proteìna melhorada através de engenharia de cepa
CN101203605B (zh) * 2004-12-17 2016-01-27 由卫生福利和体育大臣代表的荷兰王国 革兰氏阴性菌的lps的脱酰基化
AU2008245696B2 (en) 2007-04-27 2013-11-07 Pelican Technology Holdings, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
ITMI20090946A1 (it) 2009-05-28 2010-11-29 Novartis Ag Espressione di proteine ricombinanti
WO2011126811A2 (en) 2010-03-30 2011-10-13 Pfenex Inc. High level expression of recombinant toxin proteins
US9169304B2 (en) 2012-05-01 2015-10-27 Pfenex Inc. Process for purifying recombinant Plasmodium falciparum circumsporozoite protein
US20140037680A1 (en) 2012-08-06 2014-02-06 Glaxosmithkline Biologicals, S.A. Novel method
SG11201500573RA (en) 2012-08-06 2015-02-27 Glaxosmithkline Biolog Sa Method for eliciting in infants an immune response against rsv and b. pertussis
PE20151720A1 (es) 2013-03-08 2015-12-10 Crucell Holland Bv Vacuna acelular contra pertussis
EA201690115A1 (ru) 2013-08-05 2016-07-29 Глаксосмитклайн Байолоджикалс С.А. Комбинированные иммуногенные композиции
CN109172818B (zh) * 2018-08-02 2021-10-22 浙江康佰裕生物科技有限公司 一种蛋白牛痘疫苗及其效力检测方法
JP2022508713A (ja) * 2018-10-15 2022-01-19 アリゾナ ボード オブ リージェンツ オン ビハーフ オブ ザ ユニバーシティ オブ アリゾナ ワクチンポリペプチド組成物および方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4704362A (en) * 1977-11-08 1987-11-03 Genentech, Inc. Recombinant cloning vehicle microbial polypeptide expression
FR2590483B1 (fr) * 1985-11-22 1988-12-09 Pasteur Institut Antigenes purifies ayant des proprietes vaccinantes contre b. pertussis, moyens notamment adns recombinants pour les produire et compositions de vaccins les contenant
CA1340373C (en) * 1986-01-28 1999-02-02 Rino Rappuoli Cloning and sequencing of the dna fragment which codes for the five subunits of the pertussis toxin, a hybrid plasmid containing the dna fragment and micro-organisms transformed by the hybrid plasmid and capable of expressing all or some of the subunits of the pertussis toxin
ATE80179T1 (de) * 1986-12-23 1992-09-15 Univ Leland Stanford Junior Modifiziertes pertussistoxin.
IT1223334B (it) * 1987-11-02 1990-09-19 Sclavo Spa Polipeptidi immunologicamente attivi con una tossicita' alterata utili per la preparazione di un vaccino antipertosse
GB8727489D0 (en) * 1987-11-24 1987-12-23 Connaught Lab Detoxification of pertussis toxin
IT1223529B (it) * 1987-12-18 1990-09-19 Sclavo Spa Epitopo immunodominante protettivo contenuto nella subunita' s1 della tossina della pertosse

Also Published As

Publication number Publication date
KR0168039B1 (ko) 1999-01-15
NO891842L (no) 1989-06-21
DE3854213T2 (de) 1995-12-07
CN1033866C (zh) 1997-01-22
NO972642L (no) 1997-07-28
WO1989001976A1 (en) 1989-03-09
DK216289A (da) 1989-06-30
EP0306318B2 (en) 2004-04-28
NO301844B1 (no) 1997-12-15
FI101632B (fi) 1998-07-31
IE882668L (en) 1989-03-04
EP0306318B1 (en) 1995-07-26
DK216289D0 (da) 1989-05-03
AU2386488A (en) 1989-03-31
IE69753B1 (en) 1996-10-02
EP0629696A1 (en) 1994-12-21
EP0306318A1 (en) 1989-03-08
NO325016B1 (no) 2008-01-14
KR890701758A (ko) 1989-12-21
IL103121A0 (en) 1993-02-21
JP2918895B2 (ja) 1999-07-12
DE3854213D1 (de) 1995-08-31
CN1033072A (zh) 1989-05-24
FI892131A (fi) 1989-05-03
FI101632B1 (fi) 1998-07-31
GR3017497T3 (en) 1995-12-31
AU623867B2 (en) 1992-05-28
ATE125568T1 (de) 1995-08-15
DE3854213T3 (de) 2004-10-21
FI892131A0 (fi) 1989-05-03
CA1341560C (en) 2007-10-30
NO891842D0 (no) 1989-05-03
JPH04501051A (ja) 1992-02-27
IL103121A (en) 1995-08-31
US5773600A (en) 1998-06-30
ES2076160T3 (es) 1995-11-01
NO972642D0 (no) 1997-06-09
ES2076160T5 (es) 2004-12-01
DK175821B1 (da) 2005-03-14

Similar Documents

Publication Publication Date Title
GR3017497T3 (en) Recombinant DNA-derived bordetella toxin subunit analogs.
ES2156110T3 (es) Analogos de sub-unidades de toxina del colera derivados de adn recombinante.
ATE181572T1 (de) Ospa proteine von borrelia burgdorferi untergruppen, dafür kodierende gene sowie impfstoffe
HK166295A (en) Chimeric glycoproteins containing immunogenic segments of the glycoproteins of human respiratory syncytial virus
HUT69938A (en) Urease-based vaccine against helicobacter infection
NO164177C (no) Rekombinant dna-fremgangsmaate for fremstilling av et polypeptid med funksjon av human immun (gamma)-interferon.
KR970009347B1 (en) Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3
LU91595I2 (fr) Combinaison d'anatoxine diphtérique, d'anatoxine tétanique, d'anatoxine coquelucheuse, d'hémagglutinine filamenteuse, de pertactine et de polyoside capsulaire d'haemophilus influenzae type b (InfanrixHib)
DE69228944D1 (de) Bovines herpesvirus typ 1rekombinantenpolypeptide und vakzine
ATE157258T1 (de) Zubereitungen und behandlungen von pneumonia in tieren
DE69510858D1 (de) Mukosale Verabreichung von Pneumokokken-Antigenen
ZA965586B (en) Coccidiosis poultry vaccine
EP0498804A4 (en) A method of vaccine or toxoid preparation and immunization by colonization with recombinant microorganisms
IL100402A0 (en) Use of il-4 to enhance immune response to immunogens in vaccines
PT787796E (pt) Epitopos protectores de ciclase do adenilo-hemolisina (ac-hly), sua aplicação ao tratamento ou à prevenção das infecções por bordetella
EP0493575A4 (en) Rotavirus reassortant vaccine
EP0636030A4 (en) VACCINE AGAINST THE -I BACTERIAL OXIDE (PASTEURELLIA HAEMOLYTICA).
DK230890A (da) Dna-fragment, der koder for et pasteurella multocida-toxin eller for en subsekvens eller analog deraf, ekspressionsvektor, der omfatter dna-fragmentet, mikroorganisme, der udtrykker dette, fremgangsmaade til fremstilling af et pasteurella-multocida-toxin, diagnostisk middel samt anvendelse heraf, vaccine indeholdende et pasteurella-multocida-toxinderivat, anvendelse af pasteurella multocida-t m.m.

Legal Events

Date Code Title Description
KB Patent renewed
RH Patent void
KB Patent renewed
KB Patent renewed
EXP Patent expired
EXP Patent expired